Family directly observed therapy for children with drug-resistant TB

Int J Tuberc Lung Dis. 2022 Aug 1;26(8):792-794. doi: 10.5588/ijtld.22.0168.

Authors

M L Rekart¹, T Morshed², W K Mulanda², J Klieascikova³, N Sitali⁴, A Rajabzoda⁵, S Avzamova⁵, B Pirmahmadzoda⁶, A Aung², M Sayfulloev², R Sleit⁴, A Sinha⁷

Affiliations

¹ Medecins Sans Frontieres (MSF), Dushanbe, Tajikistan, MSF, Uzbekistan.
² Medecins Sans Frontieres (MSF), Dushanbe, Tajikistan.
³ MSF, Kuala Lumpur, Malaysia.
⁴ MSF Holland, Amsterdam, The Netherlands.
⁵ National Tuberculosis Programme, Dushanbe, Tajikistan.
⁶ Dushanbe City Tuberculosis Programme, Dushanbe City, Tajikistan.
⁷ Manson Unit, MSF, London, UK.

No abstract available

Publication types

Letter

MeSH terms

Antitubercular Agents / therapeutic use
Child
Directly Observed Therapy
Humans
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

Antitubercular Agents